These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 26106624)

  • 21. A Glycation Angle to Look into the Diabetic Vasculopathy: Cause and Cure.
    Ahmad S; Siddiqui Z; Rehman S; Khan MY; Khan H; Khanum S; Alouffi S; Saeed M
    Curr Vasc Pharmacol; 2017; 15(4):352-364. PubMed ID: 28356033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of microRNA-34a mediates protection of thymosin beta 4 in endothelial progenitor cells against advanced glycation endproducts by targeting B-cell lymphoma 2.
    Chen Q; Shen Z; Mao Y; Li Q; Liu Y; Mei M; Qiu F; Wang M
    Can J Physiol Pharmacol; 2019 Oct; 97(10):945-951. PubMed ID: 31397599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic memory phenomenon in diabetes mellitus: Achieving and perspectives.
    Berezin A
    Diabetes Metab Syndr; 2016; 10(2 Suppl 1):S176-83. PubMed ID: 27025794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic memory: Evolving concepts.
    Misra A; Bloomgarden Z
    J Diabetes; 2018 Mar; 10(3):186-187. PubMed ID: 29091343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular understanding of hyperglycemia's adverse effects for diabetic complications.
    Sheetz MJ; King GL
    JAMA; 2002 Nov; 288(20):2579-88. PubMed ID: 12444865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role and limits of glycemic regulation in the pathogenesis of diabetic microangiopathy.
    Le Dévéhat C; Khodabandehlou T; Zhao H; Vimeux M
    Clin Hemorheol Microcirc; 1997; 17(5):363-70. PubMed ID: 9502534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The "Metabolic Memory" Theory and the Early Treatment of Hyperglycemia in Prevention of Diabetic Complications.
    Testa R; Bonfigli AR; Prattichizzo F; La Sala L; De Nigris V; Ceriello A
    Nutrients; 2017 Apr; 9(5):. PubMed ID: 28452927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Introduction of hyperglycemia and dyslipidemia in the pathogenesis of diabetic vascular complications.
    Xu Y; He Z; King GL
    Curr Diab Rep; 2005 Apr; 5(2):91-7. PubMed ID: 15794910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidative stress and diabetic vascular complications.
    Giugliano D; Ceriello A; Paolisso G
    Diabetes Care; 1996 Mar; 19(3):257-67. PubMed ID: 8742574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular complexities underlying the vascular complications of diabetes mellitus - A comprehensive review.
    Paul S; Ali A; Katare R
    J Diabetes Complications; 2020 Aug; 34(8):107613. PubMed ID: 32505477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus.
    Hori O; Yan SD; Ogawa S; Kuwabara K; Matsumoto M; Stern D; Schmidt AM
    Nephrol Dial Transplant; 1996; 11 Suppl 5():13-6. PubMed ID: 9044300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SIRT1 Antagonizes Oxidative Stress in Diabetic Vascular Complication.
    Meng T; Qin W; Liu B
    Front Endocrinol (Lausanne); 2020; 11():568861. PubMed ID: 33304318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetes and vascular disease: basic concepts of nitric oxide physiology, endothelial dysfunction, oxidative stress and therapeutic possibilities.
    Capellini VK; Celotto AC; Baldo CF; Olivon VC; Viaro F; Rodrigues AJ; Evora PR
    Curr Vasc Pharmacol; 2010 Jul; 8(4):526-44. PubMed ID: 19485895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycemic variability in type 2 diabetes mellitus: oxidative stress and macrovascular complications.
    Johnson EL
    Adv Exp Med Biol; 2012; 771():139-54. PubMed ID: 23393677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early- and advanced non-enzymatic glycation in diabetic vascular complications: the search for therapeutics.
    Schalkwijk CG; Miyata T
    Amino Acids; 2012 Apr; 42(4):1193-204. PubMed ID: 20960212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity?
    Prattichizzo F; Giuliani A; De Nigris V; Pujadas G; Ceka A; La Sala L; Genovese S; Testa R; Procopio AD; Olivieri F; Ceriello A
    Diabetes Obes Metab; 2016 Sep; 18(9):855-67. PubMed ID: 27161301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic Modification of MicroRNA-200b Contributes to Diabetic Vasculopathy.
    Singh K; Pal D; Sinha M; Ghatak S; Gnyawali SC; Khanna S; Roy S; Sen CK
    Mol Ther; 2017 Dec; 25(12):2689-2704. PubMed ID: 29037594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Receptor for advanced glycation end products (RAGE): a novel therapeutic target for diabetic vascular complication.
    Yamagishi S; Nakamura K; Matsui T; Noda Y; Imaizumi T
    Curr Pharm Des; 2008; 14(5):487-95. PubMed ID: 18289075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of the toxic AGEs (TAGE)-RAGE system in the pathogenesis of diabetic vascular complications: a novel therapeutic strategy.
    Takeuchi M; Takino J; Yamagishi S
    Curr Drug Targets; 2010 Nov; 11(11):1468-82. PubMed ID: 20583971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of Notch signaling in diabetic endothelial progenitor cells dysfunction.
    Sukmawati D; Tanaka R; Ito-Hirano R; Fujimura S; Hayashi A; Itoh S; Mizuno H; Daida H
    J Diabetes Complications; 2016; 30(1):12-20. PubMed ID: 26598222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.